Upgrade to SI Premium - Free Trial

Insys Therapeutics (INSY) Releases Statement on Maryland Attorney General's Motion

February 9, 2018 11:24 AM
INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Litigation

Next Articles